Hairy Cell Leukemia Patient Data Registry
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study ID
- NCT02560883
- Status
- Recruiting
Conditions
- Leukemia, Other
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The overall objective is to develop a clinical data registry that can be used to facilitate research with the ultimate goal of reducing the morbidity and/or mortality and improving the quality of life of patients diagnosed or living with hairy cell leukemia. With approximately 1,000 new cases of this rare disease identified in the US each year, HCL represents 2% of all cases of leukemia in adults. Considering the rarity of this chronic leukemia, the Hairy Cell Leukemia Foundation (HCLF), in partnership with investigators from its Centers of Excellence, seeks to develop a registry to help researchers identify new trends in outcomes, recognize the most effective treatments, discover previously unknown complications of the disease, and design clinical trials for new therapies.
Key Dates
- Start date
- Jan 2, 2013
- Status verified
- Apr 2025
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 5,000 participants (estimated)
Primary Outcome Measure
Surveillance [ Time Frame: up to 25 years ]
Central Contacts
- Hairy Cell Leukemia Research Data Registry614-685-4296
- Derick Campbell614-366-5196
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami/Soffer Clinical Research Center | Miami | Florida | 33136 | Justin Taylor, M.D. (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic | Rochester | Minnesota | 55905 | Sameer Parikh, MD (PRINCIPAL_INVESTIGATOR) |
| University of Rochester /Wilmot Cancer Institute | Rochester | New York | 14642 | Clive Zent, MD (PRINCIPAL_INVESTIGATOR) |
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | Michael Grever, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
Related Studies
- Factors Affecting Post-transplant Cyclophosphamide (PTCy) EfficacyRecruiting · Wake Forest University Health Sciences · Charlotte, North Carolina